Patient access to precision medicine: Identifying barriers to biomarker testing in non-small cell lung cancer.

被引：0
|
作者：
Levent, Ayse
De Richter, Pieter
Bender, Hope
机构：
[1] Ipsos, New York, NY USA
[2] Ipsos, Kuala Lumpur, Malaysia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3131
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Precision radiotherapy for non-small cell lung cancer
    Wen-Chi Yang
    Feng-Ming Hsu
    Pan-Chyr Yang
    Journal of Biomedical Science, 27
  • [32] Using stem cell biology to design precision medicine for non-small cell lung cancer
    Fillmore, Christine M.
    Xu, Chunxiao
    Sanchez-Rivera, Francisco J.
    Jacks, Tyler
    Wong, Kwok-Kin
    Kim, Carla F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S4 - S5
  • [33] Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
    Liu, Xiaoming
    Cho, William C.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [34] Precision medicine in non-small cell lung cancer: Current applications and future directions
    Yang, Soo-Ryum
    Schultheis, Anne M.
    Yu, Helena
    Mandelker, Diana
    Ladanyi, Marc
    Buettner, Reinhard
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 184 - 198
  • [35] Access to specialist care and treatment in patients with advanced non-small cell lung cancer.
    Ganti, Apar Kishor
    Borghaei, Hossein
    Hirsch, Fred R.
    Wynes, Murry
    Ravelo, Arliene
    Ionescu-Ittu, Raluca
    Pivneva, Irina
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine
    Villaruz, Liza C.
    Socinski, Mark A.
    Weiss, Jared
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Influenza and mortality for non-small cell lung cancer.
    Kinslow, Connor J.
    Wang, Yuankun
    Liu, Yi
    Zuev, Konstantin M.
    Wang, Tony J. C.
    Donalek, Ciro M.
    Amori, Michael
    Cheng, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Locally advanced non-small cell lung cancer.
    Cohen E.E.
    Vokes E.E.
    Current Treatment Options in Oncology, 2001, 2 (1) : 27 - 42
  • [39] Biomarker utilization in non-small cell lung cancer, are we treating after testing?
    Makhoul, Elias
    Kim, Jong Taek
    Zhang, Wenjuan
    Lopategui, Jean Raphael
    Balmanoukian, Ani Sarkis
    Vail, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast
    Hirsch, Fred R.
    Kim, Chul
    ONCOLOGY AND THERAPY, 2024, 12 (02) : 223 - 231
12345